Philippe Peltier - Profile and Investment Details
Find investors who align with your industry, stage, and vision. Unlock Philippe Peltier’s full investment profile, including location, investment focus, portfolio companies, and preferences. Sign up today and start building investor relationships that fuel your startup’s growth.
Get connected with all investors today
- Health Care,
- Digital Therapeutics,
- Hospitals,
- Wellness,
- Rare Diseases,
- Healthcare Innovation,
- Telemedicine,
- CRM,
- Life Science,
- Medical Technologies,
- Education,
- Robotics,
- Information Technology (IT),
- Finance,
- Software,
- Biotechnology,
- Medical Devices,
- Drug Development,
- Electronic Health Records (EHR),
- Health and Hospital Services,
- Precision Medicine,
- Digital Transformation,
- Technology Transfer,
- Telehealth,
- Health Diagnostics,
- Digital Health,
- Medical,
- Big Data,
- Information Technology,
- B2B,
- Therapeutics,
- Health Tech,
- Pharmaceuticals
Social media:
Past investments:
- Implanet
- AM Pharma
- FeetMe
- Sunrise
- Advanced Perfusion Diagnostics
- Asceneuron
- IO Biotech
- Vico Therapeutics
- ARGOBIO
- DNA Script
- STAT-Dx
- Tacalyx
- Synendos Therapeutics
- Xeltis
- ImCheck Therapeutics
- Orphazyme
- Sensome
- Mila
- Corlieve Therapeutics
- Horama
- Minoryx Therapeutics
- Ganymed Robotics
- Meiogenix
- Safe Orthopaedics
- Step Pharma
- Lucine
- BliNK Biomedical
- ABM Pharma
- Cardiologs
- DeepUll
- Asarina Pharma
- PathoQuest
- Medlumics
- Sensome (ex-Instent)
- Alizé Pharma
- BioSerenity
- Vivet Therapeutics
- Ermium Therapeutics
- Pharvaris
- Dynacure
- DAMAE Medical
- Stilla Technologies
- OxThera
Investor Profile
Philippe Peltier is a Venture Capital, Private Equity Firm, Investor based in Paris, Île-de-France, France with a diverse investment portfolio that includes companies such as Implanet, AM Pharma, FeetMe, Sunrise, Advanced Perfusion Diagnostics, Asceneuron, IO Biotech, Vico Therapeutics, ARGOBIO, DNA Script, STAT-Dx, Tacalyx, Synendos Therapeutics, Xeltis, ImCheck Therapeutics, Orphazyme, SensomeMila, Corlieve Therapeutics, Horama, Minoryx Therapeutics, Ganymed Robotics, Meiogenix, Safe Orthopaedics, Step Pharma, Lucine, BliNK Biomedical, ABM Pharma, Cardiologs, DeepUll, Asarina Pharma, PathoQuest, Medlumics, Sensome (ex-Instent), Alizé Pharma, BioSerenity, Vivet Therapeutics, Ermium Therapeutics, Pharvaris, Dynacure, DAMAE Medical, Stilla Technologies, OxThera, . Over time, Philippe Peltier has demonstrated experience in supporting a range of businesses across various sectors.
While it is not publicly confirmed whether Philippe Peltier is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.
Startups and entrepreneurs operating in sectors related to Health Care, Digital Therapeutics, Hospitals, Wellness, Rare Diseases, Healthcare Innovation, Telemedicine, CRM, Life Science, Medical Technologies, Education, Robotics, Information Technology (IT), Finance, Software, Biotechnology, Medical Devices, Drug Development, Electronic Health Records (EHR), Health and Hospital Services, Precision Medicine, Digital Transformation, Technology Transfer, Telehealth, Health Diagnostics, Digital Health, Medical, Big Data, Information Technology, B2B, Therapeutics, Health Tech, Pharmaceuticals may find it worthwhile to explore potential connections with Philippe Peltier, as their portfolio suggests a familiarity and interest in this area.
Understanding Philippe Peltier’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.
Angel Match is the easiest way to research investors for your startup so you can spend less time Googling and more time raising.
Find the perfect investors today
